Mol Cell Biol. 1983 April; 3(4): 596-604
Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes.
C A Whitlock,
S F Ziegler and
O N Witte
ABSTRACT
Some molecular changes which correlate with the tumorigenic progression of neoplastic cells can best be studied with in vitro cell lines that represent each stage in the progression. Lymphoid cells infected by Abelson murine leukemia virus exhibit a wide range of growth potential in vitro and in vivo. Uncloned populations that are poorly oncogenic early after infection become progressively more oncogenic with successive passages of the cells in culture. In such mass cultures, it is difficult to evaluate whether a rare subpopulation of highly oncogenic cells becomes dominant in the culture or whether the individual cells progress in oncogenic phenotype. To examine this latter possibility, Abelson virus-infected lymphoid cells were cloned by limiting-dilution culture 10 days postinfection. We isolated two clones that grew poorly in agar, required feeder layers of adherent bone marrow cells for growth in liquid culture, and were extremely slow to form tumors in syngeneic animals. Both clones, after passage in the presence of adherent feeder layers for 3 months, grew well in liquid and agar-containing cultures in the absence of feeder layers and formed tumors in animals at a rapid rate. The progression of these clonal cell lines to a more malignant growth phenotype occurred in the absence of detectable changes in the concentration, half-life, phosphorylation, in vitro kinase activity, or cell localization of the Abelson virus-encoded transforming protein. No change in the concentration or arrangement of integrated Abelson viral DNA sequences was detected in either clone. Thus, perhaps changes in the expression of cellular genes would appear to alter the growth properties of lymphoid cells after their initial transformation by Abelson virus. Such cellular changes could complement the activity of the Abelson virus transforming protein in producing the fully malignant growth phenotype.
Mol Cell Biol. 1983 April; 3(4): 596-604
This article has been cited by other articles:
-
Sachs, Z., Sharpless, N. E., DePinho, R. A., Rosenberg, N.
(2004). p16Ink4a Interferes with Abelson Virus Transformation by Enhancing Apoptosis. J. Virol.
78: 3304-3311
[Abstract]
[Full Text]
-
Noronha, E. J., Sterling, K. H., Calame, K. L.
(2003). Increased Expression of Bcl-xL and c-Myc Is Associated with Transformation by Abelson Murine Leukemia Virus. J. Biol. Chem.
278: 50915-50922
[Abstract]
[Full Text]
-
Unnikrishnan, I., Rosenberg, N.
(2003). Absence of p53 Complements Defects in Abelson Murine Leukemia Virus Signaling. J. Virol.
77: 6208-6215
[Abstract]
[Full Text]
-
Nakamura, Y., Grumont, R. J., Gerondakis, S.
(2002). NF-{kappa}B1 Can Inhibit v-Abl-Induced Lymphoid Transformation by Functioning as a Negative Regulator of Cyclin D1 Expression. Mol. Cell. Biol.
22: 5563-5574
[Abstract]
[Full Text]
-
Ma, P., Magut, M., Chen, X., Chen, C.-Y.
(2002). p53 Is Necessary for the Apoptotic Response Mediated by a Transient Increase of Ras Activity. Mol. Cell. Biol.
22: 2928-2938
[Abstract]
[Full Text]
-
Jenab-Wolcott, J., Rodriguez-Correa, D., Reitmair, A. H., Mak, T., Rosenberg, N.
(2000). The Absence of Msh2 Alters Abelson Virus Pre-B-Cell Transformation by Influencing p53 Mutation. Mol. Cell. Biol.
20: 8373-8381
[Abstract]
[Full Text]
-
Mostecki, J., Halgren, A., Radfar, A., Sachs, Z., Ravitz, J., Thome, K. C., Rosenberg, N.
(2000). Loss of Heterozygosity at the Ink4a/Arf Locus Facilitates Abelson Virus Transformation of Pre-B Cells. J. Virol.
74: 9479-9487
[Abstract]
[Full Text]
-
Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., Rosenberg, N.
(1999). p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells. Mol. Cell. Biol.
19: 4825-4831
[Abstract]
[Full Text]
-
Radfar, A., Unnikrishnan, I., Lee, H.-W., DePinho, R. A., Rosenberg, N.
(1998). p19Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl. Acad. Sci. USA
95: 13194-13199
[Abstract]
[Full Text]
-
Daley, G., McLaughlin, J, Witte, O., Baltimore, D
(1987). The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science
237: 532-535
[Abstract]
Copyright © 1983 by the American Society for Microbiology. All rights reserved.